Lynch Asset Management, Inc. Dexcom Inc Transaction History

Lynch Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$86.06 - $137.93 $94,666 - $151,723	-1,100 Reduced 14.86%	6,300 $587,000
Q2 2023 Jul 17, 2023	SELL	$112.47 - $130.98 $67,482 - $78,588	-600 Reduced 7.5%	7,400 $950,000
Q1 2023 Apr 20, 2023	SELL	$104.0 - $122.92 $384,800 - $454,804	-3,700 Reduced 31.62%	8,000 $929,000
Q4 2022 Jan 20, 2023	SELL	$84.98 - $122.67 $25,494 - $36,801	-300 Reduced 2.5%	11,700 $0
Q2 2022 Jul 21, 2022	BUY	$67.99 - $132.89 $656,103 - $1.28 Million	9,650 Added 410.64%	12,000 $895,000
Q4 2021 Feb 02, 2022	BUY	$129.87 - $162.82 $305,194 - $382,627	2,350 New	2,350 $1.26 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Lynch Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Lynch Asset Management, Inc. with notifications on news.